Evidence map›Paper›PMID 26861955›Full record

ArticleNeurotoxicity research2016

An In Vitro Study of the Neurotoxic Effects of N-Benzylpiperazine: A Designer Drug of Abuse.

Karolina Persona, Anna Polus, Joanna Góralska, Anna Gruca, Aldona Dembińska-Kieć, Wojciech Piekoszewski

Open access · hybridAbstract read
In one paragraph

Article in Neurotoxicity research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. An Update on the Implications of New Psychoactive Substances in Public Health.International journal of environmental research and public health · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Karolina PersonaDepartment of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University in Krakow, Ingardena 3, 30-060, Kraków, Poland.
Anna PolusDepartment of Clinical Biochemistry, Jagiellonian University in Krakow - Medical College, Kraków, Poland.
Joanna GóralskaDepartment of Clinical Biochemistry, Jagiellonian University in Krakow - Medical College, Kraków, Poland.
Anna GrucaDepartment of Clinical Biochemistry, Jagiellonian University in Krakow - Medical College, Kraków, Poland.
Aldona Dembińska-KiećDepartment of Clinical Biochemistry, Jagiellonian University in Krakow - Medical College, Kraków, Poland.
Wojciech PiekoszewskiDepartment of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University in Krakow, Ingardena 3, 30-060, Kraków, Poland. wpiekosz@tlen.pl.
Jagiellonian University · PLFar Eastern Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the number of new psychoactive substances has significantly increased. Despite the systematic introduction of prohibition in trade of medicinal products which mimic the effects of illegal drugs, the problem concerning this group of drugs is still important although knowledge about the mechanism of action of those types of substances is scarce. This study aimed to follow the neurotoxic effect of N-benzylpiperazine (BZP), the central nervous system psychostimulant, using the human cancer LN-18 cell model. The statistically significant elevation of LDH levels, increased mitochondrial membrane potential, decreased ATP and increased ROS production, increased levels of DNA damage marker (8-OHdG) and activation of caspases: -3 and -9 confirmed by Real-Time PCR imply the activation of mitochondrial proapoptotic pathways induced by BZP after 24 h incubation. This study is a novel, preliminary attempt to explain the toxicity of one of the most popular designer drug of abuse at the cellular level.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdenosine Triphosphatebcl-2-Associated X ProteinCaspasesCell Line, TumorDeoxyguanosineDose-Response Relationship, DrugGene Expression Regulation, NeoplasticGlioblastomaHumansL-Lactate DehydrogenaseMembrane Potential, MitochondrialNeurotoxinsPiperazinesProto-Oncogene Proteins c-bcl-2Reactive Oxygen Species8-Hydroxy-2'-DeoxyguanosineAdenosine Triphosphatebcl-2-Associated X ProteinCaspasesDeoxyguanosineL-Lactate DehydrogenaseN-benzylpiperazineNeurotoxinsPiperazinesProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesRELA protein, humanRNA, MessengerTranscription Factor RelAApoptosisBenzylpiperazineNeurodegenerationNew psychoactive substancesOxidative stress

Identifiers

PMID26861955
PMCPMC4820481
OpenAlexW2260878091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.